TREASURY INTELLIGENCE / CAPITAL ALLOCATION
Intercompany Treasury & Consolidated Cash Flow
Capital pipeline monitoring, ROI simulation, transfer pricing control and subsidiary liquidity analysis.
Total Inflow (MTD)
$2.26M
+8.4% VS LAST MONTH
Tax Provision
$285K
Q3 SCHEDULED
Intercompany Eliminations
$605K
3 TX ELIMINATED
Net Free Cash Flow
$1.37M
POST-TAX CONSOLIDATED
Intercompany Capital Flow Pipelines
Live Sync
Aethel-Labs → Aethel-Health (Software Licensing)
$420,000
Aethel-Retail → Aethelgard Group (Dividend Upstream)
$1,250,000
Aethel-Health → Aethelgard Group (Management Fees)
$310,000
Aethelgard Group → Tax Provision Reserve
$285,000
Cash Flow Breakdown
Dividends 55%
Licensing 19%
Mgmt Fees 14%
Tax Reserve 12%
Pipeline sync: pandas .groupby() active
Currency Base: USD ($)
Capital Injection ROI Simulator
Capital Injection Amount
$500,000
Target Subsidiary
Projected Output
Projected Annual ROI
24.8%
Est. Payback Period
4.0 Years
Net Return (5Y)
$620,000
Subsidiary Liquidity Health
Transfer Pricing Ledger
Intercompany transactions · elimination filter active
| Transaction ID | From (Debtor) | To (Creditor) | Description | Amount | Treatment |
|---|
Quarterly Consolidated Cash Flow Trend
FY 2025 — Q2 2026
Aethel-Health
Aethel-Retail
Aethel-Labs